Interestingly, CLL development in these mice was linked to the expression of a restricted BCR repertoire (VHQ52/V κ9 or VH3609/V κ21, reactive toward non-muscle myosin-IIA or Thy-1, respectively) independent of CD40 signaling. Here, BCR is linked to B-cell chronic lymphocytic leukemia.